Polyphosphates inhibit extracellular matrix mineralization in MC3T3-E1 osteoblast cultures

Area of Science:

• Biochemistry
• Cell Biology
• Biomineralization Research

Background:

• Phosphate compounds play a crucial role in biomineralization.
• Inorganic polyphosphates (PolyP) are ubiquitous in mammalian systems, with high levels in osteoblasts, but their function in bone is poorly understood.
• Previous studies show PolyP inhibits hydroxyapatite formation in cell-free systems and ectopic calcification in vivo.

Purpose of the Study:

• To investigate the role of inorganic polyphosphates (PolyP5 and PolyP65) in regulating mineralization in osteoblast cultures.
• To determine the mechanism by which PolyP affects mineralization, specifically its interaction with hydroxyapatite and tissue-nonspecific alkaline phosphatase (TNAP).

Main Methods:

• MC3T3-E1 osteoblast cultures were treated with PolyP5 or PolyP65 in the presence of ascorbic acid and β-glycerophosphate.
• Mineralization was assessed using Von Kossa staining and calcium quantification.
• PolyP binding to synthetic hydroxyapatite and TNAP activity were measured.

Main Results:

• PolyP5 and PolyP65 potently inhibited osteoblast mineralization in a dose-dependent manner, with complete inhibition at 10μM.
• PolyP treatment did not affect cell proliferation or collagen assembly, indicating direct inhibition of mineralization.
• PolyP5 and PolyP65 bound to hydroxyapatite and competitively inhibited TNAP activity, affecting pyrophosphate and β-glycerophosphate hydrolysis.

Conclusions:

• Inorganic polyphosphates are potent inhibitors of bone mineralization through direct interaction with hydroxyapatite.
• PolyP inhibits mineralization by competitively inhibiting TNAP, potentially by shielding pyrophosphate from degradation.
• Polyphosphates represent a novel regulatory mechanism in biomineralization processes.